{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:13:26Z","timestamp":1769062406761,"version":"3.49.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,11]],"date-time":"2012-08-11T00:00:00Z","timestamp":1344643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10753-012-9517-7","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T07:49:58Z","timestamp":1344584998000},"page":"35-41","source":"Crossref","is-referenced-by-count":24,"title":["Is the IL-10 Promoter Polymorphism at Position -592 Associated with Immune System-Related Diseases?"],"prefix":"10.1007","volume":"36","author":[{"given":"Mojgan Noroozi","family":"Karimabad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Kazemi","family":"Arababadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Hakimizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan Yousefi","family":"Daredori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamhossein","family":"Hassanshahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,11]]},"reference":[{"key":"9517_CR1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/35003235","volume":"403","author":"YJ Chiang","year":"2000","unstructured":"Chiang, Y.J., H.K. Kole, K. Brown, et al. 2000. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403: 216\u2013220.","journal-title":"Nature"},{"key":"9517_CR2","doi-asserted-by":"crossref","unstructured":"Arababadi, M.K., B.N. Ahmadabadi, and D. Kennedy. 2012. Current information on the immunological status of occult hepatitis B infection. Transfusion. doi: 10.1111\/j.1537-2995.2012.03575.x .","DOI":"10.1111\/j.1537-2995.2012.03575.x"},{"key":"9517_CR3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0264-410X(02)00538-8","volume":"21","author":"W Eden van","year":"2003","unstructured":"van Eden, W., A. Koets, P. van Kooten, et al. 2003. Immunopotentiating heat shock proteins: negotiators between innate danger and control of autoimmunity. Vaccine 21: 897\u2013901.","journal-title":"Vaccine"},{"key":"9517_CR4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaci.2009.03.001","volume":"123","author":"M Miyara","year":"2009","unstructured":"Miyara, M., K. Wing, and S. Sakaguchi. 2009. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. The Journal of Allergy and Clinical Immunology 123: 749\u2013755. quiz 756\u2013747.","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"9517_CR5","first-page":"S163","volume":"16","author":"YP Li","year":"2006","unstructured":"Li, Y.P., V. Latger-Canard, L. Marchal, et al. 2006. The regulatory role of dendritic cells in the immune tolerance. Biomedical Materials and Engineering 16: S163\u2013S170.","journal-title":"Biomedical Materials and Engineering"},{"key":"9517_CR6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2222.2003.01577.x","volume":"33","author":"J Karjalainen","year":"2003","unstructured":"Karjalainen, J., J. Hulkkonen, M.M. Nieminen, et al. 2003. Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma. Clinical and Experimental Allergy 33: 78\u201383.","journal-title":"Clinical and Experimental Allergy"},{"key":"9517_CR7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"Sawcer, S., G. Hellenthal, M. Pirinen, et al. 2011. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214\u2013219.","journal-title":"Nature"},{"key":"9517_CR8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2217\/bmm.10.81","volume":"4","author":"MK Arababadi","year":"2010","unstructured":"Arababadi, M.K., R. Mosavi, H. Khorramdelazad, et al. 2010. Cytokine patterns after therapy with Avonex(R), Rebif(R), Betaferon(R) and CinnoVex in relapsing-remitting multiple sclerosis in Iranian patients. Biomarkers in Medicine 4: 755\u2013759.","journal-title":"Biomarkers in Medicine"},{"key":"9517_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1309\/LM9TU9ID1CGZVLXL","volume":"41","author":"MK Arababadi","year":"2010","unstructured":"Arababadi, M.K., G. Hassanshahi, H. Azin, et al. 2010. No association between CCR5 \u224f 32 mutation and multiple sclerosis in patients of south-eastern of Iran. Laboratory Medicine 41: 31\u201333.","journal-title":"Laboratory Medicine"},{"issue":"2","key":"9517_CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5144\/0256-4947.2012.127","volume":"32","author":"MK Arababadi","year":"2011","unstructured":"Arababadi, M.K., R. Mosavi, H. Teimori, et al. 2011. Association of IL-4 polymorphisms with multiple sclerosis in south-eastern Iranian patients. Annals of Saudi Medicine 32(2): 127\u2013130.","journal-title":"Annals of Saudi Medicine"},{"key":"9517_CR11","first-page":"107","volume":"14","author":"MK Arababadi","year":"2011","unstructured":"Arababadi, M.K., H. Abousaidi, G. Hassanshahi, et al. 2011. Association of exon 9 but not intron 8 VDR polymorphisms with asthma in south-eastern Iranian patients. Iranian Journal of Basic Medical Science 14: 107\u2013115.","journal-title":"Iranian Journal of Basic Medical Science"},{"key":"9517_CR12","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1038\/35037002","volume":"402","author":"W Cookson","year":"1999","unstructured":"Cookson, W. 1999. The alliance of genes and environment in asthma and allergy. Nature 402: B5\u2013B11.","journal-title":"Nature"},{"key":"9517_CR13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1586\/ers.10.57","volume":"4","author":"K Orihara","year":"2011","unstructured":"Orihara, K., N. Dil, V. Anaparti, et al. 2011. What\u2019s new in asthma pathophysiology and immunopathology? Expert Review of Respiratory Medicine 4: 605\u2013629.","journal-title":"Expert Review of Respiratory Medicine"},{"issue":"1","key":"9517_CR14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2217\/bmm.11.84","volume":"6","author":"N Yaghini","year":"2011","unstructured":"Yaghini, N., M. Mahmoodi, G. Asadikaram, et al. 2011. Genetic variation of IL-12B (+1188 region) is associated with its decreased circulating levels and susceptibility to type 2 diabetes: a study on south-eastern Iranian diabetic patients. Biomarkers in Medicine 6(1): 89\u201395.","journal-title":"Biomarkers in Medicine"},{"key":"9517_CR15","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/BF03346417","volume":"31","author":"M Cruz","year":"2008","unstructured":"Cruz, M., C. Maldonado-Bernal, R. Mondragon-Gonzalez, et al. 2008. Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes. Journal of Endocrinological Investigation 31: 694\u2013699.","journal-title":"Journal of Endocrinological Investigation"},{"issue":"10","key":"9517_CR16","first-page":"752","volume":"13","author":"N Yaghini","year":"2011","unstructured":"Yaghini, N., M. Mahmoodi, G. Asadikaram, et al. 2011. Serum levels of Interleukin 10 (IL-10) in patients with type 2 diabetes. Iranian Red Crescent Medical Journal 13(10): 752.","journal-title":"Iranian Red Crescent Medical Journal"},{"key":"9517_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.diabres.2009.09.027","volume":"87","author":"MK Arababadi","year":"2009","unstructured":"Arababadi, M.K., R. Nosratabadi, G. Hassanshahi, et al. 2009. Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases? Diabetes Research and Clinical Practice 87: 33\u201337.","journal-title":"Diabetes Research and Clinical Practice"},{"key":"9517_CR18","first-page":"100","volume":"12","author":"MK Arababadi","year":"2009","unstructured":"Arababadi, M.K., A.A. Pourfathollah, S. Daneshmandi, et al. 2009. Evaluation of relation between IL-4 and IFN-g polymorphisms and type 2 diabetes. Iranian Journal of Basic Medical Science 12: 100\u2013104.","journal-title":"Iranian Journal of Basic Medical Science"},{"key":"9517_CR19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4103\/0256-4947.55177","volume":"29","author":"MK Arababadi","year":"2009","unstructured":"Arababadi, M.K., N. Naghavi, G. Hassanshahi, et al. 2009. Is CCR5-Delta32 mutation associated with diabetic nephropathy in type 2 diabetes? Annals of Saudi Medicine 29: 413.","journal-title":"Annals of Saudi Medicine"},{"key":"9517_CR20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0896-8411(03)00044-1","volume":"20","author":"H Groux","year":"2003","unstructured":"Groux, H., and F. Cottrez. 2003. The complex role of interleukin-10 in autoimmunity. Journal of Autoimmunity 20: 281\u2013285.","journal-title":"Journal of Autoimmunity"},{"key":"9517_CR21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10689-005-0072-3","volume":"5","author":"WM Howell","year":"2006","unstructured":"Howell, W.M., and M.J. Rose-Zerilli. 2006. Interleukin-10 polymorphisms, cancer susceptibility and prognosis. Familial Cancer 5: 143\u2013149.","journal-title":"Familial Cancer"},{"key":"9517_CR22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","volume":"21","author":"R Sabat","year":"2010","unstructured":"Sabat, R., G. Grutz, K. Warszawska, et al. 2010. Biology of interleukin-10. Cytokine & Growth Factor Reviews 21: 331\u2013344.","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"9517_CR23","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore, K.W., R. de Waal Malefyt, R.L. Coffman, et al. 2001. Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 19: 683\u2013765.","journal-title":"Annual Review of Immunology"},{"key":"9517_CR24","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0140-6736(05)63055-3","volume":"349","author":"R Booy","year":"1997","unstructured":"Booy, R., S. Nadel, M. Hibberd, et al. 1997. Genetic influence on cytokine production in meningococcal disease. Lancet 349: 1176.","journal-title":"Lancet"},{"key":"9517_CR25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jns.2010.12.005","volume":"303","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y., J. Zhang, C. Tian, et al. 2011. The -1082G\/A polymorphism in IL-10 gene is associated with risk of Alzheimer\u2019s disease: a meta-analysis. Journal of Neurological Sciences 303: 133\u2013138.","journal-title":"Journal of Neurological Sciences"},{"key":"9517_CR26","doi-asserted-by":"crossref","first-page":"838390","DOI":"10.1155\/2010\/838390","volume":"2010","author":"P Lopez","year":"2010","unstructured":"Lopez, P., C. Gutierrez, and A. Suarez. 2010. IL-10 and TNFalpha genotypes in SLE. Journal of Biomedicine and Biotechnology 2010: 838390.","journal-title":"Journal of Biomedicine and Biotechnology"},{"key":"9517_CR27","first-page":"12","volume":"2011","author":"P Scapini","year":"2011","unstructured":"Scapini, P., C. Lamagna, Y. Hu, et al. 2011. B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 2011: 12.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9517_CR28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.immuni.2008.03.003","volume":"28","author":"MO Li","year":"2008","unstructured":"Li, M.O., and R.A. Flavell. 2008. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 28: 468\u2013476.","journal-title":"Immunity"},{"key":"9517_CR29","first-page":"302","volume":"4","author":"MK Arababadi","year":"2010","unstructured":"Arababadi, M.K. 2010. Interleukin-4 gene polymorphisms in type 2 diabetic patients with nephropathy. Iranian Journal of Kidney Diseases 4: 302\u2013306.","journal-title":"Iranian Journal of Kidney Diseases"},{"key":"9517_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1744-313X.2010.00953.x","volume":"37","author":"R Nosratabadi","year":"2010","unstructured":"Nosratabadi, R., M.K. Arababadi, V.A. Salehabad, et al. 2010. Polymorphisms within exon 9 but not intron 8 of the vitamin D receptor are associated with the nephropathic complication of type-2 diabetes. International Journal of Immunogenetics 37: 1\u20135.","journal-title":"International Journal of Immunogenetics"},{"issue":"3","key":"9517_CR31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10753-011-9376-7","volume":"35","author":"MK Arababadi","year":"2011","unstructured":"Arababadi, M.K., M. Mirzaei, S.M.A. Sajadi, et al. 2011. Interleukin (IL)-10 gene polymorphisms is associated with type 2 diabetes with and without nephropathy: a study of patients from the South-East region of Iran. Inflammation 35(3): 797\u2013802.","journal-title":"Inflammation"},{"key":"9517_CR32","doi-asserted-by":"crossref","unstructured":"Chang, J.H., H.R. Cha, D.S. Lee, et al. 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One 5: e12925.","DOI":"10.1371\/journal.pone.0012925"},{"key":"9517_CR33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/dmrr.892","volume":"25","author":"N Mtiraoui","year":"2009","unstructured":"Mtiraoui, N., I. Ezzidi, M. Kacem, et al. 2009. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients. Diabetes\/Metabolism Research and Reviews 25: 57\u201363.","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"key":"9517_CR34","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1089\/dia.2010.0085","volume":"12","author":"WJ Kung","year":"2011","unstructured":"Kung, W.J., C.C. Lin, S.H. Liu, et al. 2011. Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy. Diabetes Technology & Therapeutics 12: 809\u2013813.","journal-title":"Diabetes Technology & Therapeutics"},{"key":"9517_CR35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2265.2008.03337.x","volume":"70","author":"I Ezzidi","year":"2009","unstructured":"Ezzidi, I., N. Mtiraoui, M. Kacem, et al. 2009. Interleukin-10-592C\/A, -819C\/T and -1082A\/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients. Clinical Endocrinology 70: 401\u2013407.","journal-title":"Clinical Endocrinology"},{"key":"9517_CR36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.imlet.2005.03.001","volume":"99","author":"M Ishii","year":"2005","unstructured":"Ishii, M., G. Hasegawa, M. Fukui, et al. 2005. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000\u00a0U\/ml) of antibodies to glutamic acid decarboxylase. Immunology Letters 99: 180\u2013185.","journal-title":"Immunology Letters"},{"key":"9517_CR37","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2337\/db06-0047","volume":"55","author":"D Scarpelli","year":"2006","unstructured":"Scarpelli, D., M. Cardellini, F. Andreozzi, et al. 2006. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects. Diabetes 55: 1529\u20131533.","journal-title":"Diabetes"},{"key":"9517_CR38","doi-asserted-by":"crossref","unstructured":"Ascherio, A., K.L. Munger, K.C. Simon. Vitamin D and multiple sclerosis. Lancet Neurology 9: 599\u2013612.","DOI":"10.1016\/S1474-4422(10)70086-7"},{"key":"9517_CR39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/17520363.1.1.111","volume":"1","author":"CE Teunissen","year":"2007","unstructured":"Teunissen, C.E., J. Killestein, and G. Giovannoni. 2007. Biomarker research in multiple sclerosis: addressing axonal damage and heterogeneity. Biomarkers in Medicine 1: 111\u2013119.","journal-title":"Biomarkers in Medicine"},{"key":"9517_CR40","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass, C.K., K. Saijo, B. Winner, et al. 2010. Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918\u2013934.","journal-title":"Cell"},{"issue":"2","key":"9517_CR41","first-page":"127","volume":"32","author":"R Nosratabadi","year":"2011","unstructured":"Nosratabadi, R., B.N. Ahmadabadi, M.K. Arababadi, et al. 2011. Association of polymorphism in the -592 region of IL-10 with multiple sclerosis in south-eastern Iranian patients. Iranian Red Crescent Medical Journal 32(2): 127\u2013130.","journal-title":"Iranian Red Crescent Medical Journal"},{"key":"9517_CR42","first-page":"200","volume":"13","author":"L Almeras","year":"2002","unstructured":"Almeras, L., B. Meresse, J. Seze, et al. 2002. Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression. European Cytokine Network 13: 200\u2013206.","journal-title":"European Cytokine Network"},{"key":"9517_CR43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1196\/annals.1354.034","volume":"1067","author":"GI Forte","year":"2006","unstructured":"Forte, G.I., P. Ragonese, G. Salemi, et al. 2006. Search for genetic factors associated with susceptibility to multiple sclerosis. Annals of the New York Academy of Sciences 1067: 264\u2013269.","journal-title":"Annals of the New York Academy of Sciences"},{"key":"9517_CR44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1034\/j.1600-0404.2003.00165.x","volume":"108","author":"M Luomala","year":"2003","unstructured":"Luomala, M., T. Lehtimaki, H. Huhtala, et al. 2003. Promoter polymorphism of IL-10 and severity of multiple sclerosis. Acta Neurologica Scandinavica 108: 396\u2013400.","journal-title":"Acta Neurologica Scandinavica"},{"key":"9517_CR45","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jneuroim.2005.06.020","volume":"168","author":"S Mihailova","year":"2005","unstructured":"Mihailova, S., M. Ivanova, A. Mihaylova, et al. 2005. Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients. Journal of Neuroimmunology 168: 138\u2013143.","journal-title":"Journal of Neuroimmunology"},{"key":"9517_CR46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1468-1331.2004.01102.x","volume":"12","author":"S Wergeland","year":"2005","unstructured":"Wergeland, S., A. Beiske, H. Nyland, et al. 2005. IL-10 promoter haplotype influence on interferon treatment response in multiple sclerosis. European Journal of Neurology 12: 171\u2013175.","journal-title":"European Journal of Neurology"},{"key":"9517_CR47","first-page":"107","volume":"19","author":"N Azarpira","year":"2010","unstructured":"Azarpira, N., A. Borhani Haghighi, M. Pourjafar, et al. 2010. Interleukin 10 gene polymorphism in Iranian patients with multiple sclerosis. Acta Neurologica Taiwanica 19: 107\u2013111.","journal-title":"Acta Neurologica Taiwanica"},{"key":"9517_CR48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-5728(99)00146-0","volume":"101","author":"C Pickard","year":"1999","unstructured":"Pickard, C., C. Mann, P. Sinnott, et al. 1999. Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis. Journal of Neuroimmunology 101: 207\u2013210.","journal-title":"Journal of Neuroimmunology"},{"key":"9517_CR49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1067\/mai.2001.116122","volume":"108","author":"AJ Sandford","year":"2001","unstructured":"Sandford, A.J., S. Zhu, T.R. Bai, et al. 2001. The role of the C-C chemokine receptor-5 Delta32 polymorphism in asthma and in the production of regulated on activation, normal T cells expressed and secreted. The Journal of Allergy and Clinical Immunology 108: 69\u201373.","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"9517_CR50","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.rmed.2008.03.010","volume":"102","author":"Z Zietkowski","year":"2008","unstructured":"Zietkowski, Z., M.M. Tomasiak, R. Skiepko, et al. 2008. RANTES in exhaled breath condensate of stable and unstable asthma patients. Respiratory Medicine 102: 1198\u20131202.","journal-title":"Respiratory Medicine"},{"key":"9517_CR51","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/SMJ.0b013e3182186ff0","volume":"104","author":"H Abousaidi","year":"2011","unstructured":"Abousaidi, H., R. Vazirinejad, M.K. Arababadi, et al. 2011. Lack of association between chemokine receptor 5 (CCR5) C32 mutation and pathogenesis of asthma: a study on Iranian asthma patients. Southern Medical Journal 104: 422\u2013425.","journal-title":"Southern Medical Journal"},{"key":"9517_CR52","doi-asserted-by":"crossref","first-page":"e14299","DOI":"10.1371\/journal.pone.0014299","volume":"5","author":"K Pukelsheim","year":"2010","unstructured":"Pukelsheim, K., T. Stoeger, D. Kutschke, et al. 2010. Cytokine profiles in asthma families depend on age and phenotype. PLoS One 5: e14299.","journal-title":"PLoS One"},{"key":"9517_CR53","unstructured":"Hakimizadeh, E., M.K. Arababadi, G. Hassanshahi, et al. 2012. Association of -592 region of IL-10 polymorphisms with asthma in south-eastern Iranian patients. Clinical Laboratory 58: 267\u2013271."},{"key":"9517_CR54","first-page":"114","volume":"82","author":"J Zhang","year":"2002","unstructured":"Zhang, J., H. Chen, L. Hu, et al. 2002. Correlation between polymorphism of IL-4 and IL-10 gene promoter and childhood asthma and their impact upon cytokine expression. Zhonghua Yi Xue Za Zhi 82: 114\u2013118.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"9517_CR55","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1080\/02770900802207261","volume":"45","author":"M Movahedi","year":"2008","unstructured":"Movahedi, M., S.A. Mahdaviani, N. Rezaei, et al. 2008. IL-10, TGF-beta, IL-2, IL-12, and IFN-gamma cytokine gene polymorphisms in asthma. The Journal of Asthma 45: 790\u2013794.","journal-title":"The Journal of Asthma"},{"key":"9517_CR56","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1164\/ajrccm.158.6.9804011","volume":"158","author":"K Hobbs","year":"1998","unstructured":"Hobbs, K., J. Negri, M. Klinnert, et al. 1998. Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. American Journal of Respiratory and Critical Care Medicine 158: 1958\u20131962.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"9517_CR57","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/humu.1194","volume":"18","author":"T Immervoll","year":"2001","unstructured":"Immervoll, T., S. Loesgen, G. Dutsch, et al. 2001. Fine mapping and single nucleotide polymorphism association results of candidate genes for asthma and related phenotypes. Human Mutation 18: 327\u2013336.","journal-title":"Human Mutation"},{"key":"9517_CR58","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1398-9995.2009.01989.x","volume":"64","author":"SH Kim","year":"2009","unstructured":"Kim, S.H., E.M. Yang, H.N. Lee, et al. 2009. Combined effect of IL-10 and TGF-beta1 promoter polymorphisms as a risk factor for aspirin-intolerant asthma and rhinosinusitis. Allergy 64: 1221\u20131225.","journal-title":"Allergy"},{"key":"9517_CR59","first-page":"143","volume":"7","author":"D Trajkov","year":"2008","unstructured":"Trajkov, D., J. Mirkovska-Stojkovikj, T. Arsov, et al. 2008. Association of cytokine gene polymorphisms with bronchial asthma in Macedonians. Iranian Journal of Allergy, Asthma, and Immunology 7: 143\u2013156.","journal-title":"Iranian Journal of Allergy, Asthma, and Immunology"},{"key":"9517_CR60","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2500\/aap.2008.29.3123","volume":"29","author":"M Zedan","year":"2008","unstructured":"Zedan, M., A. Settin, M.K. Farag, et al. 2008. Gene polymorphisms of tumor necrosis factor alpha-308 and interleukin-10-1082 among asthmatic Egyptian children. Allergy and Asthma Proceedings 29: 268\u2013273.","journal-title":"Allergy and Asthma Proceedings"},{"key":"9517_CR61","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2222.2005.02273.x","volume":"35","author":"R Chatterjee","year":"2005","unstructured":"Chatterjee, R., J. Batra, A. Kumar, et al. 2005. Interleukin-10 promoter polymorphisms and atopic asthma in North Indians. Clinical and Experimental Allergy 35: 914\u2013919.","journal-title":"Clinical and Experimental Allergy"},{"key":"9517_CR62","doi-asserted-by":"crossref","unstructured":"Kazemi Arababadi, M., M. Reza Mirzaei, S.M. Ali Sajadi, et al. Interleukin (IL)-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: a study of patients from the southeast region of Iran. Inflammation 35: 797\u2013802.","DOI":"10.1007\/s10753-011-9376-7"},{"key":"9517_CR63","doi-asserted-by":"crossref","unstructured":"Kung, W.J., C.C. Lin, S.H. Liu, et al. Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy. Diabetes Technology & Therapeutics 12: 809\u2013813.","DOI":"10.1089\/dia.2010.0085"},{"key":"9517_CR64","unstructured":"Hakimizadeh, E., M.K. Arababadi, G. Hassanshahi, et al. Association of -592 region of IL-10 polymorphisms with asthma in south-eastern Iranian patients. Clinical Laboratory 58: 267\u2013271."}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-012-9517-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-012-9517-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-012-9517-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T14:26:16Z","timestamp":1562077576000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-012-9517-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,11]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["9517"],"URL":"https:\/\/doi.org\/10.1007\/s10753-012-9517-7","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,11]]}}}